NEW YORK (GenomeWeb News) – France's National Institute of Health and Medical Research (INSERM) is coordinating a European multi-partner project that will conduct metagenomics-based studies of gut microbes to understand the causes of and find ways to treat cardiometabolic diseases (CMDs), INSERM said on Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.